These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 34406623)
1. Determining the extent of tumor resection at surgical planning with Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623 [TBL] [Abstract][Full Text] [Related]
2. Phase IIa clinical study of [ Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267 [TBL] [Abstract][Full Text] [Related]
3. Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466 [No Abstract] [Full Text] [Related]
4. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. Schreibmann E; Schuster DM; Rossi PJ; Shelton J; Cooper S; Jani AB Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):206-13. PubMed ID: 27511856 [TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
6. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance and Safety of Positron Emission Tomography Using Wakabayashi T; Iuchi T; Tsuyuguchi N; Nishikawa R; Arakawa Y; Sasayama T; Miyake K; Nariai T; Narita Y; Hashimoto N; Okuda O; Matsuda H; Kubota K; Ito K; Nakazato Y; Kubomura K Asia Ocean J Nucl Med Biol; 2017; 5(1):10-21. PubMed ID: 28840134 [TBL] [Abstract][Full Text] [Related]
11. Michaud L; Beattie BJ; Akhurst T; Dunphy M; Zanzonico P; Finn R; Mauguen A; Schöder H; Weber WA; Lassman AB; Blasberg R Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1353-1367. PubMed ID: 31418054 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings. Doi Y; Kanagawa M; Maya Y; Tanaka A; Oka S; Nakata N; Toyama M; Matsumoto H; Shirakami Y Nucl Med Biol; 2015 Aug; 42(8):664-72. PubMed ID: 26022202 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial. Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314 [TBL] [Abstract][Full Text] [Related]
14. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas. Karlberg A; Berntsen EM; Johansen H; Skjulsvik AJ; Reinertsen I; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L Clin Nucl Med; 2019 Jul; 44(7):550-559. PubMed ID: 31107743 [TBL] [Abstract][Full Text] [Related]
15. Prospective Clinical Trial of Ulaner GA; Goldman DA; Corben A; Lyashchenko SK; Gönen M; Lewis JS; Dickler M J Nucl Med; 2017 Jul; 58(7):1037-1042. PubMed ID: 27856630 [No Abstract] [Full Text] [Related]